Top Companies: Glioma Therapeutics Market Challenges and Opportunities 2019 - 2027

Glioma Therapeutics Market: Emerging Chemotherapies can be Effective Treatment Options
Glioma is a condition which covers a broad category of brain and spinal cord tumors that come from glial cells in brain that support nerve cells. Glioma can affect brain function and may be fatal depending on its location and severity of tumor.
View Report : https://www.transparencymarketresearch.com/glioma-therapeutics-market.html

Glial cells are cells in brain which surround and support neurons in the brain including astrocytes, oligodendrocytes, and ependymal cells. Glioma is a common type of tumor originating in the brain which is formed in these glial cells.
Glioma has different types such as astrocytoma, brain stem gliomas, ependymomas, mixed gliomas (oligo-astrocytomas), oligodendrogliomas, and optic pathway gliomas
Risk factors may range from older age (more common in adults between 45-65 years of age) and radiation exposure to family history of glioma
Various therapeutic options are available for the treatment of glioma such as radiation therapy, chemotherapy, targeted drug therapy, and surgery. Late stage clinical pipeline drugs can be effective treatment options for glioma in the next few years.
Key Drivers and Restraints of Global Glioma Therapeutics Market
Expected approval of late-stage pipeline molecules and orphan drug designation to certain molecules for the treatment of glioma are some of the major factors responsible for the growth of the global glioma therapeutics market
For instance, on December 05, 2019, U.S. FDA and European Medicines Agency granted orphan drug designation to Adastra Pharmaceuticals drug zotiraciclib, a multikinase inhibitor. This products is being evaluated in two phase 1b clinical studies of patients with glioblastoma, the most common glioma histology for the treatment of glioma.
Growing prevalence of brain cancer and rising awareness regarding various types of brain tumors are some of the major factors fuelling the growth of global glioma therapeutics market
Moreover, strategic alliances for the development of glioma therapeutics products and increase in exposure of humans to radiation in recent times which leads to higher incidence of brain cancer are some of the major factors responsible for the growth of the global glioma therapeutics market
Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76325

Adverse Effects of Chemotherapy Hamper Market:
Regrowth of tumor after treatment & surgery in many cases and adverse effects of chemotherapy are some of the factors hampering the growth of the global glioma therapeutics market
Increase in investment in developing new molecules and unsuccessful trials can also negatively impact the global glioma therapeutics market
Chemotherapy Segment to be Highly Lucrative Segment
Based on therapy type, global glioma therapeutics market can be segmented into chemotherapy, targeted drug therapy, radiation therapy, and surgery
REQUEST FOR COVID19 IMPACT ANALYSIS - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76325

Chemotherapy is a highly promising segment of the market which is expected to show significant growth during the forecast period, owing to expected launch and approval of new molecules for glioma treatment and higher investment of companies for pipeline products in this category
The chemotherapy segment is further sub-segmented into Temozolomide, Bevacizumab, Carmustine, and others
Low Grade Gliomas to be Promising Grade Segment
In terms of grade, the global glioma therapeutics market can be divided into low-grade gliomas, high-grade gliomas, and recurrent high-grade gliomas
The low-grade gliomas segment is anticipated to be a highly lucrative segment in the near future due to more treatment options availability and early detection of tumor of this grade
Primary Dominated Tumor Type Segment
Based on tumor type, the global glioma therapeutics market can be bifurcated into primary tumors and secondary tumors
Primary tumors are further sub-divided into astrocytoma, ependymoma, brain stem gliomas, oligodendrogliomas, mixed gliomas, and others
Primary tumors dominated the global glioma therapeutics market as they are a more prevalent form of tumors across the world
Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=76325

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.